CD357 / GITR(GITR/1585), 0.2mg/mL |
|||
| BNUB1585-100 | Biotium | 1uL | EUR 225 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD357 / GITR(GITR/1585), 0.2mg/mL |
|||
| BNUB1585-500 | Biotium | 1uL | EUR 485 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
GITR |
|||
| MBS344090-INQUIRE | MyBiosource | INQUIRE | Ask for price |
CD357 / GITR(GITR/1585), CF568 conjugate, 0.1mg/mL |
|||
| BNC681585-100 | Biotium | 1uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD357 / GITR(GITR/1585), CF568 conjugate, 0.1mg/mL |
|||
| BNC681585-500 | Biotium | 1uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD357 / GITR(GITR/1585), CF594 conjugate, 0.1mg/mL |
|||
| BNC941585-100 | Biotium | 1uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD357 / GITR(GITR/1585), CF594 conjugate, 0.1mg/mL |
|||
| BNC941585-500 | Biotium | 1uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD357 / GITR(GITR/1585), CF647 conjugate, 0.1mg/mL |
|||
| BNC471585-100 | Biotium | 1uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD357 / GITR(GITR/1585), CF647 conjugate, 0.1mg/mL |
|||
| BNC471585-500 | Biotium | 1uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD357 / GITR(GITR/1585), CF488A conjugate, 0.1mg/mL |
|||
| BNC881585-100 | Biotium | 1uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD357 / GITR(GITR/1585), CF488A conjugate, 0.1mg/mL |
|||
| BNC881585-500 | Biotium | 1uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD357 / GITR(GITR/1585), Biotin conjugate, 0.1mg/mL |
|||
| BNCB1585-100 | Biotium | 1uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD357 / GITR(GITR/1585), Biotin conjugate, 0.1mg/mL |
|||
| BNCB1585-500 | Biotium | 1uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD357 / GITR(GITR/1585), CF640R conjugate, 0.1mg/mL |
|||
| BNC401585-100 | Biotium | 1uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD357 / GITR(GITR/1585), CF640R conjugate, 0.1mg/mL |
|||
| BNC401585-500 | Biotium | 1uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD357 / GITR(GITR/1585), CF405S conjugate, 0.1mg/mL |
|||
| BNC041585-100 | Biotium | 1uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD357 / GITR(GITR/1585), CF405S conjugate, 0.1mg/mL |
|||
| BNC041585-500 | Biotium | 1uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD357/GITR |
|||
| MBS4381365-002mgWithBSAAzideat02mgmL | MyBiosource | 0.02mg(WithBSA&Azideat0.2mg/mL) | EUR 230 |
CD357/GITR |
|||
| MBS4381365-01mgWithBSAAzideat02mgmL | MyBiosource | 0.1mg(WithBSA&Azideat0.2mg/mL) | EUR 405 |
CD357/GITR |
|||
| MBS4381365-01mgWithoutBSAAzideat1mgmL | MyBiosource | 0.1mg(WithoutBSA&Azideat1mg/mL) | EUR 405 |
CD357/GITR |
|||
| MBS4381365-5x01mgWithBSAAzideat02mgmL | MyBiosource | 5x0.1mg(WithBSA&Azideat0.2mg/mL) | EUR 1725 |
CD357/GITR |
|||
| MBS4381365-5x01mgWithoutBSAAzideat1mgmL | MyBiosource | 5x0.1mg(WithoutBSA&Azideat1mg/mL) | EUR 1725 |
GITR Antibody |
|||
| E10-31522 | EnoGene | 100ul | EUR 225 |
|
Description: Available in various conjugation types. |
|||
GITR Mouse mAb |
|||
| E2M50095 | EnoGene | 100ul | EUR 255 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
GITR Mouse mAb |
|||
| E2222299 | EnoGene | 100ul | EUR 255 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
GITR Rabbit mAb |
|||
| E2R90013 | EnoGene | 100ul | EUR 585 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
TNFSF18 (GITR Ligand) |
|||
| MBS692721-01mg | MyBiosource | 0.1mg | EUR 725 |
TNFSF18 (GITR Ligand) |
|||
| MBS692721-5x01mg | MyBiosource | 5x0.1mg | EUR 2965 |
TNFSF18 (GITR Ligand) |
|||
| MBS692722-01mg | MyBiosource | 0.1mg | EUR 725 |
TNFSF18 (GITR Ligand) |
|||
| MBS692722-5x01mg | MyBiosource | 5x0.1mg | EUR 2965 |
GITR Recombinant Protein |
|||
| 90-216 | ProSci | 50 ug | EUR 600.9 |
|
Description: GITR (Glucocorticoid-induced TNF receptor) is the receptor for TNFSF18. It is involved in interactions between activated T-lymphocytes and endothelial cells and in the regulation of T cell receptor-mediated cell death. GITR serves as a negative regulator for NK cell activation. It mediates NF-kappaB activation via the TRAF2/NIK pathway. |
|||
GITR Recombinant Protein |
|||
| 90-238 | ProSci | 50 ug | EUR 651.3 |
|
Description: GITR (Glucocorticoid-induced TNF receptor) is the receptor for TNFSF18. It is involved in interactions between activated T-lymphocytes and endothelial cells and in the regulation of T cell receptor-mediated cell death. GITR serves as a negative regulator for NK cell activation. It mediates NF-kappaB activation via the TRAF2/NIK pathway. |
|||
GITR Recombinant Protein |
|||
| 91-947 | ProSci | 0.05 mg | EUR 588.3 |
|
Description: Tumor necrosis factor receptor superfamily member 18(Gitr) contains 3 TNFR-Cys repeats and it have four isforms.IsformA、isformB and isformC is single-pass type I membrane protein and isformD is a secreted protein. The protein is the receptor for TNFSF18.It seems to be involved in interactions between activated T-lymphocytes and endothelial cells and in the regulation of T-cell receptor-mediated cell death. It mediated NF-kappa-B activation via the TRAF2/NIK pathway.It binds to TRAF1, TRAF2, and TRAF3, but not TRAF5 and TRAF6 and binds through its C-terminus to SIVA1/SIVA.It preferentially expressed in activated T lymphocytes and up-regulated in peripherical mononuclear cells after antigen stimulation/lymphocyte activation. |
|||
GITR Recombinant Protein |
|||
| 97-041 | ProSci | 0.1 mg | EUR 651.3 |
|
Description: Glucocorticoid-induced TNFR-related protein (GITR) is also known as Tumor necrosis factor receptor superfamily member 18 (TNFRSF18), activation-inducible TNFR family receptor (AITR), CD antigen CD357, which is a member of the tumor necrosis factor receptor (TNF-R) superfamily. GITR is receptor for TNFSF18, which seems to be involved in interactions between activated T-lymphocytes and endothelial cells and in the regulation of T-cell receptor-mediated cell death. GITR also mediated NF-kappa-B activation via the TRAF2/NIK pathway. |
|||
GITR Recombinant Protein |
|||
| 97-042 | ProSci | 0.1 mg | EUR 651.3 |
|
Description: Glucocorticoid-induced TNFR-related protein (GITR) is also known as Tumor necrosis factor receptor superfamily member 18 (TNFRSF18), activation-inducible TNFR family receptor (AITR), CD antigen CD357, which is a member of the tumor necrosis factor receptor (TNF-R) superfamily. GITR is receptor for TNFSF18, which seems to be involved in interactions between activated T-lymphocytes and endothelial cells and in the regulation of T-cell receptor-mediated cell death. GITR also mediated NF-kappa-B activation via the TRAF2/NIK pathway. |
|||
GITR Recombinant Protein |
|||
| 97-064 | ProSci | 0.1 mg | EUR 714.3 |
|
Description: Glucocorticoid-induced TNFR-related protein (GITR) is also known as Tumor necrosis factor receptor superfamily member 18 (TNFRSF18), activation-inducible TNFR family receptor (AITR), CD antigen CD357, which is a member of the tumor necrosis factor receptor (TNF-R) superfamily. GITR is receptor for TNFSF18, which seems to be involved in interactions between activated T-lymphocytes and endothelial cells and in the regulation of T-cell receptor-mediated cell death. GITR also mediated NF-kappa-B activation via the TRAF2/NIK pathway. |
|||
GITR Recombinant Protein |
|||
| 92-712 | ProSci | 0.05 mg | EUR 374.1 |
|
Description: GITR Recombinant Protein |
|||
GITR Recombinant Protein |
|||
| 96-997 | ProSci | 0.1 mg | EUR 714.3 |
|
Description: Glucocorticoid-induced TNFR-related protein (GITR) is also known as Tumor necrosis factor receptor superfamily member 18 (TNFRSF18), activation-inducible TNFR family receptor (AITR), CD antigen CD357, which is a member of the tumor necrosis factor receptor (TNF-R) superfamily. GITR is receptor for TNFSF18, which seems to be involved in interactions between activated T-lymphocytes and endothelial cells and in the regulation of T-cell receptor-mediated cell death. GITR also mediated NF-kappa-B activation via the TRAF2/NIK pathway. |
|||
GITR-L Rabbit mAb |
|||
| E2R90104 | EnoGene | 100ul | EUR 585 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
GITR (CD357), Fc fusion |
|||
| 71172 | BPS Bioscience | 100 µg | EUR 300 |
|
Description: Human secreted GITR, Fc fusion protein, also known as Glucocorticoid-induced TNFR-Related Protein, Tumor Necrosis Factor Receptor Superfamily member 18, TNFRSF18, Activation-Inducible TNFR Family Receptor, AITR, and CD357, GenBank Accession No. NM_004195, a.a. 26-161 expressed in a HEK293 cell expression system. MW = 41.2 kDa (monomer). This protein runs at a higher MW by SDS-PAGE due to glycosylation. |
|||
Mouse GITR ELISA Kit |
|||
| MBS825068-5x96Tests | MyBiosource | 5x96Tests | EUR 2880 |
Mouse GITR ELISA Kit |
|||
| MBS825068-96Tests | MyBiosource | 96Tests | EUR 645 |
Human GITR ELISA Kit |
|||
| MBS824888-5x96Tests | MyBiosource | 5x96Tests | EUR 2880 |
Human GITR ELISA Kit |
|||
| MBS824888-96Tests | MyBiosource | 96Tests | EUR 645 |
Human GITR ELISA Kit |
|||
| SEKH-0192 | Solarbio Life Science |
|
|
Mouse GITR ELISA Kit |
|||
| SEKM-0303 | Solarbio Life Science |
|
|
Human GITR/TNFRSF18 Fc |
|||
| MBS692555-002mg | MyBiosource | 0.02mg | EUR 300 |
Human GITR/TNFRSF18 Fc |
|||
| MBS692555-01mg | MyBiosource | 0.1mg | EUR 450 |
Human GITR/TNFRSF18 Fc |
|||
| MBS692555-5x01mg | MyBiosource | 5x0.1mg | EUR 1725 |
GITR-GFP-NFkB-TAR |
|||
| LTV-0091-1 | LipExoGen | 2x10^6 | EUR 895 |
|
Description: VSV-G |
|||
GITR-RFP-NFkB-TAG |
|||
| LTV-0091-2 | LipExoGen | 2x10^6 | EUR 895 |
|
Description: VSV-G |
|||
GITR/TNFRSF18 Rabbit pAb |
|||
| A15625 | Abclonal | 100μL | EUR 623.48 |
GiTR (CD357) Antibody (FITC) |
|||
| 20-abx200778 | Abbexa |
|
|
GITR/TNFRSF18 Rabbit pAb |
|||
| E45R22191N | EnoGene | 50 ul | EUR 297.75 |
GITR-GFP-NFkB-Gluc |
|||
| LTV-0091-3 | LipExoGen | 2x10^6 | EUR 895 |
|
Description: VSV-G |
|||
GITR-RFP-NFkB-Gluc |
|||
| LTV-0091-4 | LipExoGen | 2x10^6 | EUR 895 |
|
Description: VSV-G |
|||
GITR/TNFRSF18 Rabbit pAb |
|||
| MBS9144907-002mL | MyBiosource | 0.02mL | EUR 200 |
GITR/TNFRSF18 Rabbit pAb |
|||
| MBS9144907-005mL | MyBiosource | 0.05mL | EUR 255 |
GITR/TNFRSF18 Rabbit pAb |
|||
| MBS9144907-01mL | MyBiosource | 0.1mL | EUR 345 |
GITR/TNFRSF18 Rabbit pAb |
|||
| MBS9144907-02mL | MyBiosource | 0.2mL | EUR 545 |
GITR/TNFRSF18 Rabbit pAb |
|||
| MBS9144907-5x02mL | MyBiosource | 5x0.2mL | EUR 2265 |